JPH0155268B2 - - Google Patents
Info
- Publication number
- JPH0155268B2 JPH0155268B2 JP2282883A JP2282883A JPH0155268B2 JP H0155268 B2 JPH0155268 B2 JP H0155268B2 JP 2282883 A JP2282883 A JP 2282883A JP 2282883 A JP2282883 A JP 2282883A JP H0155268 B2 JPH0155268 B2 JP H0155268B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydrogen atom
- lower alkyl
- different
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 115
- 150000001875 compounds Chemical class 0.000 claims description 68
- 125000000217 alkyl group Chemical group 0.000 claims description 64
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 49
- 238000004519 manufacturing process Methods 0.000 claims description 37
- 125000003118 aryl group Chemical group 0.000 claims description 36
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 36
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 33
- 229910052801 chlorine Inorganic materials 0.000 claims description 32
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 26
- 125000000304 alkynyl group Chemical group 0.000 claims description 21
- 125000001188 haloalkyl group Chemical group 0.000 claims description 21
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 20
- 125000002947 alkylene group Chemical group 0.000 claims description 19
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 claims description 15
- 229910021529 ammonia Inorganic materials 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 12
- 230000036772 blood pressure Effects 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- -1 β-chloroethyl group Chemical group 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 19
- 238000000034 method Methods 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 8
- 230000003276 anti-hypertensive effect Effects 0.000 description 8
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 230000000304 vasodilatating effect Effects 0.000 description 8
- 230000002411 adverse Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000007810 chemical reaction solvent Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 4
- MOTRZVVGCFFABN-UHFFFAOYSA-N hexane;2-propan-2-yloxypropane Chemical compound CCCCCC.CC(C)OC(C)C MOTRZVVGCFFABN-UHFFFAOYSA-N 0.000 description 4
- 230000001631 hypertensive effect Effects 0.000 description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- LCNQMPRQBNCYHG-UHFFFAOYSA-N diethyl 1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=CNC=C(C(=O)OCC)C1 LCNQMPRQBNCYHG-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- DBATYLRHIGWZIO-HYXAFXHYSA-N ethyl (z)-3-amino-4-carbamoyloxybut-2-enoate Chemical compound CCOC(=O)\C=C(/N)COC(N)=O DBATYLRHIGWZIO-HYXAFXHYSA-N 0.000 description 2
- FNXKXMLUFGEZRI-UHFFFAOYSA-N ethyl 4-carbamoyloxybut-2-ynoate Chemical compound CCOC(=O)C#CCOC(N)=O FNXKXMLUFGEZRI-UHFFFAOYSA-N 0.000 description 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 229960001597 nifedipine Drugs 0.000 description 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- HQQULPUXSRHOGE-UHFFFAOYSA-N 1,4-Pentadiyn-3-one Chemical class C#CC(=O)C#C HQQULPUXSRHOGE-UHFFFAOYSA-N 0.000 description 1
- LLMLNAVBOAMOEE-UHFFFAOYSA-N 2,3-dichlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1Cl LLMLNAVBOAMOEE-UHFFFAOYSA-N 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940085304 dihydropyridine derivative selective calcium channel blockers with mainly vascular effects Drugs 0.000 description 1
- 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- KAOHYMHKNXJUFY-HYXAFXHYSA-N ethyl (z)-2-aminobut-2-enoate Chemical compound CCOC(=O)C(\N)=C\C KAOHYMHKNXJUFY-HYXAFXHYSA-N 0.000 description 1
- NIBDOTGDRGURII-UHFFFAOYSA-N ethyl 2-[(2,3-dichlorophenyl)methylidene]-3-oxobutanoate Chemical compound CCOC(=O)C(C(C)=O)=CC1=CC=CC(Cl)=C1Cl NIBDOTGDRGURII-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004262 preparative liquid chromatography Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000005920 sec-butoxy group Chemical group 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical group ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
ç£æ¥äžã®å©çšåé
æ¬çºæã¯å»è¬ã®åéã§æçšãªæ°èŠïŒïŒïŒâãžã
ããããªãžã³èªå°äœãããã«è©³ããã¯ãïŒâïŒçœ®
æãŸãã¯ç¡çœ®æã¢ããïŒã«ã«ããã«ãªãã·ã¢ã«ã
ã«âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«
ãã³é žå¯Ÿç§°ãŸãã¯é察称ãžãšã¹ãã«èªå°äœããã®
補é æ³ããã³ãã®çšéã«é¢ããã åŸæ¥æè¡ããã³çºæã解決ããããšããèª²é¡ åŸæ¥ããïŒïŒïŒâãžãããããªãžã³éªšæ Œãæã
ã埪ç°åšå®çšè¬ãšããŠã¯ããããšãžãã³
ïŒNifedipineïŒïŒïŒïŒâãžã¡ãã«ãïŒïŒïŒâãžã¡
ãã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâãžã
ããããªãžã³âïŒïŒïŒâãžã«ã«ããã·ã©ãŒãïŒç±³
åœç¹èš±ç¬¬3485847å·å ¬å ±åç §ïŒãç¥ãããŠããã
ãŸããïŒâïŒçœ®æãŸãã¯ç¡çœ®æã¢ããïŒã«ã«ãã
ã«ãªãã·ã¢ã«ãã«åºãæããïŒïŒïŒâãžãããã
ãªãžã³èªå°äœã¯ãç¹éæ57â118565å·å ¬å ±ããã³
å57â175166å·å ¬å ±çã«é瀺ãããŠãããããã
ãªãããæ¢åã®ïŒïŒïŒâãžãããããªãžã³èªå°äœ
ãæããè¡ç®¡æ¡åŒµäœçšããã³å®å šæ§ã¯ãå åãšã¯
ããããããåªããè¡ç®¡æ¡åŒµäœçšããã³è¡å§éäž
äœçšãæãããã€æ¯æ§ã極ããŠåŒ±ããå»è¬ãšããŠ
æçšãªååç©ãæ±ããããŠããã 課é¡ã解決ããããã®æ段 æ¬çºæè ãã¯ãããåªããè¡ç®¡æ¡åŒµäœçšããã³
è¡å§éäžäœçšãæããå®å šæ§ã«åªããïŒïŒïŒâãž
ãããããªãžã³èªå°äœãåµè£œãã¹ãéæç 究ãã
çµæãïŒïŒïŒâãžãããããªãžã³æ žã®ïŒäœã«ïŒçœ®
æãŸãã¯ç¡çœ®æã¢ããïŒã«ã«ããã«ãªãã·ã¢ã«ã
ã«åºãæãã該ããªãžã³æ žã®ïŒäœããã³ïŒäœã«å¯Ÿ
称ãŸãã¯é称ã®äœçŽã¢ã«ãã«ãªãã·ã«ã«ããã«åº
ãæããæ°èŠãªïŒïŒïŒâãžãããããªãžã³èªå°äœ
ããæ¢åã®ïŒïŒïŒâãžãããããªãžã³èªå°äœã«æ¯
ã¹ãŠãåªããè¡ç®¡æ¡åŒµäœçšãæãããã€æ¯æ§ã匱
ãããšãèŠåºãæ¬çºæãå®æããã æ¬çºæã¯ãäžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠã
ãŠäœçŽã¢ã«ãã«åºãR6ããã³R7ã¯åäžãŸãã¯ç°
ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽã
ãã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ã
ã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãã¯çŽé
ç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããäœãã
R1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã§
ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ããã§
è¡šãããïŒïŒïŒâãžãããããªãžã³èªå°äœããã®
補é æ³ããã³ãã®çšéã«é¢ããã 次ã«ãæ¬æ现æžäžã«èšèŒãããåçš®çšèªã«ã€ã
ãŠèª¬æããã äœçŽã¢ã«ãã«åºãšã¯ãççŽ æ°ïŒãªããïŒåãã
ãªãçŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã«åºã瀺ããäŸ
ãã°ã¡ãã«åºããšãã«åºããããã«åºãã€ãœãã
ãã«åºãããã«åºãã€ãœããã«åºãsecâããã«
åºãtertâããã«åºããã³ãã«åºãããã·ã«åºç
ãæããããã äœçŽã¢ã«ã³ãã·åºãšã¯ãçæ°çŽ ïŒãªããïŒåã
ããªãçŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ã³ãã·åºã瀺
ããäŸãã°ã¡ããã·åºããšããã·åºãããããã·
åºãã€ãœããããã·åºããããã·åºãã€ãœããã
ã·åºãsecâãããã·åºãtertâãããã·åºãã
ã³ãã«ãªãã·åºãããã·ã«ãªãã·åºçãæããã
ãã äœçŽããã¢ã«ãã«åºãšã¯ãåèšã®äœçŽã¢ã«ãã«
åºã«ããã²ã³ååã眮æããããã¢ã«ãã«åºã瀺
ããäŸãã°Î²âã¯ãããšãã«åºãβâããã¢ãšã
ã«åºãβâã¯ãããããã«åºãβïŒÎ²âãžã¯ãã
ãšãã«åºãβïŒÎ²ïŒÎ²âããªã¯ãããšãã«åºçã
æããããã äœçŽã¢ã«ããã«åºãšã¯ãçæ°çŽ ïŒãªããïŒåã
ããªãã¢ã«ããã«åºã瀺ããäŸãã°ãããã«ã®ã«
åºãïŒâãããã«åºçãæããããã ã·ã¯ãã¢ã«ãã«åºãšã¯ãäŸãã°ã·ã¯ããããã«
åºãã·ã¯ãããã«åºãã·ã¯ããã³ãã«åºãã·ã¯ã
ããã·ã«åºãã·ã¯ããããã«åºçãæããããã ãžäœçŽã¢ã«ãã«ã¢ããåºãšã¯ãåèšã®äœçŽã¢ã«
ãã«åºã眮æãããžã¢ã«ãã«ã¢ããåºã瀺ããäŸ
ãã°ãžã¡ãã«ã¢ããåºããžãšãã«ã¢ããåºããšã
ã«ã¡ãã«ã¢ããåºçãæããããã ã¢ã©ã«ãã«åºãšã¯ãäŸãã°ãã³ãžã«åºãããšã
ãã«åºãαâã¡ãã«ãã³ãžã«åºçãæããããã ã¢ãªãŒã«åºãšã¯ãäŸãã°ããšãã«åºããããã«
åºã眮æããšãã«åºïŒäœãããã®çœ®æåºãšããŠ
ã¯ãããã²ã³ååããããåºãäœçŽã¢ã«ãã«åºã
äœçŽã¢ã«ã³ãã·åºããžäœçŽã¢ã«ãã«ã¢ããåºãã
ã³ã·ã¢ãåºçãæããããïŒçãæããããã çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºãšã¯ãçæ°
çŽ ïŒãªããïŒåãããªãã¢ã«ãã¬ã³åºã瀺ããäŸ
ãã°ã¡ãã¬ã³åºããšãã¬ã³åºããããã¬ã³åºãã
ãã©ã¡ãã¬ã³åºãã¡ãã«ã¡ãã¬ã³åºããžã¡ãã«ã¡
ãã¬ã³åºçãæããããã äžè¬åŒããã®ååç©ã«ãããŠãR1ããã³R2
ã¯åäžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãå¡©çŽ åå
ãŸãã¯ãããåºã瀺ããäœããR1ããã³R2ã®ã
ã¥ããäžæ¹ãæ°ŽçŽ ååã®ãšããä»æ¹ã¯å¡©çŽ ååãŸ
ãã¯ãããåºãæå³ãããŸãäžæ¹ããããåºã®ãš
ããä»æ¹ã¯æ°ŽçŽ ååãæå³ãããR1ããã³R2ã
å¡©çŽ ååã§ããååç©ã¯ãè¯å¥œãªè¬ç掻æ§ãæã
ãã ãŸããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠ
ããŠäœçŽã¢ã«ãã«åºã瀺ãããççŽ æ°ïŒãªããïŒ
åã®ã¢ã«ãã«åºãç¹ã«å¥œãŸããã R6ããã³R7ã¯åäžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ
ååãäœçŽã¢ã«ãã«åºãäœçŽããã¢ã«ãã«åºãäœ
çŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«
åºãŸãã¯ã¢ãªãŒã«åºã瀺ããé£æ¥ããçªçŽ ååãš
å ±ã«çœ®æãŸãã¯ç¡çœ®æã®ã¢ããåºã圢æãããäœ
ããR1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœ
çŽã¢ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºã§ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ã
ããããç¹ã«R6ããã³R7ãæ°ŽçŽ ååã®ååç©ã¯ã
è¯å¥œãªè¬ç掻æ§ãæããã 次ã«ãæ¬çºæååç©ã®è£œé æ³ã«ã€ããŠèª¬æã
ãã æ¬çºæã®äžè¬åŒããã®ååç©ã¯ã以äžã®è£œé
æ³ïŒ¡ã補é æ³ïŒ¢ã補é æ³ïŒ£ããã³è£œé æ³ïŒ€ã®ãã
ãã®æ¹æ³ã«ãã€ãŠã補é ããããšãã§ããã 補é æ³ ïŒ¡ æ¬è£œé æ³ã«ããã°ãäžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠããŠäœ
çŽã¢ã«ãã«åºã瀺ããã§è¡šãããååç©ãšãåå¿
ãããããšã«ããäžè¬åŒããã®ååç©ã補é ã
ãããšãã§ããã 補é æ³ ïŒ¢ æ¬è£œé æ³ã«ããã°ãäžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããã§è¡šãããååç©ãš äžè¬åŒãã R5âCOCH2COOR3 ãã ãåŒäžãR3ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠããŠ
äœçŽã¢ã«ãã«åºã瀺ããã§è¡šãããååç©ãšãå
å¿ãããããšã«ãããäžè¬åŒããã®ååç©ã補
é ããããšãã§ããã 補é æ³ ïŒ£ æ¬è£œé æ³ã«ããã°ãäžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããã§è¡šãããååç©ãšã¢ã³ã¢ãã¢ãããã¯ã
ã®å¡©ãšãåå¿ãããããšã«ãããäžè¬åŒããã®
ååç©ã補é ããããšãã§ããã 補é æ³ ïŒ€ æ¬è£œé æ³ã«ããã°ãäžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããã§è¡šãããååç©ãš äžè¬åŒãã R5âCOCH2COOR3 ãã ãåŒäžãR3ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠããŠ
äœçŽã¢ã«ãã«åºã瀺ããã§è¡šãããååç©ãšã¢ã³
ã¢ãã¢ãããã¯ãã®å¡©ãšãåå¿ãããããšã«ã
ããäžè¬åŒããã®ååç©ã補é ããããšãã§ã
ãã 以äžã«ãæ¬çºæã®äžè¬åŒããã®ååç©ã®è£œé
æ³ã«ã€ããŠè©³çŽ°ã«èª¬æããã 補é æ³ ïŒ¡ æ¬è£œé æ³ã¯ãäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãžãªãã³ååç©ãšãåå¿
ãããããšã«ãããäžè¬åŒããã®ååç©ã補é
ãããã®ã§ããã äžè¬åŒããã®ååç©ã補é ããéã®åå¿æ¡ä»¶
ã¯ã䜿çšãããåæååç©ã®çš®é¡ã«ããé©å®éžæ
ãããããéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ã«å¯ŸããŠãäžè¬åŒããã®ãã³ãžãªãã³ååç©
ã®äœ¿çšéã¯åå¿ã«ç¹ã«æªåœ±é¿ãåãŒããªãéãã
èªç±ã«å€ããããšãã§ãããã奜ãŸããã¯ã該ã
ããã³é žãšã¹ãã«ãšã»ãŒçã¢ã«äœ¿çšãããåå¿æº¶
åªãšããŠã¯ãåå¿ã«æªåœ±é¿ãåãŒããªããã®ã§ã
ãã°ç¹ã«éå®ãããªãããæ°ŽãäžæŽ»æ§ææ©æº¶åªãŸ
ãã¯æ°ŽãšäžæŽ»æ§ææ©æº¶åªãšã®æ··å溶åªãæããã
ãã 奜ãŸããåå¿æº¶åªãšããŠã¯ãäŸãã°æ°ŽïŒã¡ã¿ã
ãŒã«ããšã¿ããŒã«ããããããŒã«ãã€ãœãããã
ãŒã«äžŠã³ã«ãã¿ããŒã«çã®ã¢ã«ã³ãŒã«ïŒãžãšãã«
ãšãŒãã«ããšãã«ã¡ãã«ãšãŒãã«äžŠã³ã«ãžã€ãœã
ããã«ãšãŒãã«çã®ãšãŒãã«ïŒãžãªããµã³ããã
ã©ããããã©ã³ãã¢ã»ããããªã«ãã¢ã»ãã³ã
ïŒïŒ®âãžã¡ãã«ãã«ã ã¢ãããé ¢é žãšãã«ãã
ã³ãŒã³ããžã¯ããã¡ã¿ã³ããã³ã¯ãããã«ã çã®
äžæŽ»æ§ææ©æº¶åªããã³æ°Žãšãããã®äžæŽ»æ§ææ©æº¶
åªãšã®æ··å溶åªãæããããã åå¿ã¯ãéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãžãªãã³ååç©ã該åå¿
溶åªã«æº¶è§£ããæ¹æäžã宀枩ãªããå ç±äžã奜ãŸ
ããã¯60ãªãã70âã®å ç±äžã§è¡ããããåå¿æ
éã«ã¯ãç¹ã«éå®ã¯ãªãããåå¿ã¯ïŒãªãã24æ
éã§å®çµããã ãŸãã觊åªãšããŠãé ¢é žãããããªã³é žçã®æ
æ©é žããããªãžã³ãããã©ãžã³ããžã€ãœãããã«
ã¢ãã³çã®ææ©å¡©åºãé©éæ·»å ããããšã«ããã
該åå¿ã¯ä¿é²ãããã æ¬è£œé æ³ã«ããåæãããäžè¬åŒããã®åå
ç©ã¯ãåå¿çµäºåŸãææ©æº¶åªãçšããæœåºåŠçã
ã¢ã«ãããã·ãªã«ã²ã«çã®æ äœãçšããã¯ããã
ã°ã©ãã€ãŒã«ããåé¢ç²Ÿè£œåŠçããã³çµæ¶ååŠç
çã®éåžžã®æ¹æ³ããèŠããã°è©²åŠçãé©å®çµåã
ãŠè¡ãããšã«ãããåé¢ã粟補ãåé¢ããã³æ¡å
ããããšãã§ããã 補é æ³ ïŒ¢ æ¬è£œé æ³ã¯ãäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãºã¢ã«ããããšäžè¬åŒ
ããã®Î²âã±ããšã¹ãã«ååç©ãšãåå¿ããã
ããšã«ãããäžè¬åŒããã®ååç©ã補é ããã
ã®ã§ããã äžè¬åŒããã®ååç©ã補é ããéã®åå¿æ¡ä»¶
ã¯ã䜿çšãããåæååç©ã®çš®é¡ã«ããé©å®éžæ
ãããããéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ã«å¯ŸããŠãäžè¬åŒããã®ãã³ãºã¢ã«ãããã
ãã³äžè¬åŒããã®Î²âã±ããšã¹ãã«ååç©ã®äœ¿
çšéã¯ãåå¿ã«ç¹ã«æªåœ±é¿ãåãŒããªãéããèª
ç±ã«å€ããããšãã§ãããã奜ãŸããã¯è©²ããã
ã³é žãšã¹ãã«ãšå€«ã ã»ãŒçã¢ã«é䜿çšããã æ¬è£œé æ³ã®åå¿æº¶åªãåå¿æž©åºŠãåå¿æéãå
é¢ç²Ÿè£œåŠçã®æäœæ¹æ³ã¯ã補é æ³ïŒ¡ãšåæ§ã«è¡ã
ããšãã§ããã 補é æ³ ïŒ£ æ¬è£œé æ³ã¯ãäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãžãªãã³ååç©ãšã¢ã³ã¢
ãã¢ãããã¯ãã®å¡©ãšãåå¿ãããããšã«ããã
äžè¬åŒããã®ååç©ã補é ãããã®ã§ããã äžè¬åŒããã®ååç©ã補é ããéã®åå¿æ¡ä»¶
ã¯ã䜿çšãããåæååç©ã®çš®é¡ã«ããé©å®éžæ
ãããããéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ã«å¯ŸããŠãäžè¬åŒããã®ãã³ãžãªãã³ååç©
ã®äœ¿çšéã¯åå¿ã«ç¹ã«æªåœ±é¿ãåãŒããªãéãã
èªç±ã«å€ããããšãã§ãããã奜ãŸããã¯è©²ãã
ãã³é žãšã¹ãã«ãšã»ãŒçã¢ã«é䜿çšããããŸãã
ã¢ã³ã¢ãã¢ãããã¯ãã®å¡©ã¯ã該ãããã³é žãšã¹
ãã«ã«å¯Ÿãéå°é䜿çšããããšãã§ããããåå¿
ã«æªåœ±é¿ãåãŒããªãéããèªç±ã«å€ããããšã
ã§ãããã¢ã³ã¢ãã¢ãããã¯ãã®å¡©ãšããŠã¯ãäŸ
ãã°ã¢ã³ã¢ãã¢ïŒè»é žãé ¢é žãé ç³é žãå®æ¯éŠ
é žãããšãã«é ¢é žçã®ææ©é žãšã®ã¢ã³ã¢ããŠã
å¡©ïŒçé žãããŠé žçã®ç¡æ©é žãšã®ã¢ã³ã¢ããŠã å¡©
çãæããããã æ¬è£œé æ³ã®åå¿æº¶åªãåå¿æž©åºŠãåå¿æéãå
é¢ç²Ÿè£œåŠçã®æäœæ¹æ³ã¯ã補é æ³ïŒ¡ãšåæ§ã«è¡ã
ããšãã§ããã 補é æ³ ïŒ€ æ¬è£œé æ³ã¯ãäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãºã¢ã«ããããšäžè¬åŒ
ããã®Î²âã±ããšã¹ãã«ååç©ãšã¢ã³ã¢ãã¢ã
ããã¯ãã®å¡©ãšãåå¿ãããããšã«ãããäžè¬åŒ
ããã®ååç©ã補é ãããã®ã§ããã äžè¬åŒããã®ååç©ã補é ããéã®åå¿æ¡ä»¶
ã¯ã䜿çšãããåæååç©ã®çš®é¡ã«ããé©å®éžæ
ãããããéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ã«å¯ŸããŠãäžè¬åŒããã®ãã³ãºã¢ã«ãããã
ãã³äžè¬åŒããã®Î²âã±ããšã¹ãã«ååç©ã®äœ¿
çšéã¯åå¿ã«ç¹ã«æªåœ±é¿ãåãŒããªãéããèªç±
ã«å€ããããšãã§ãããã該ãããã³é žãšã¹ãã«
ãšããããã»ãŒçã¢ã«é䜿çšããã®ã奜ãŸããã
ãŸããã¢ã³ã¢ãã¢ãããã¯ãã®å¡©ã¯ã該ãããã³
é žãšã¹ãã«ã«å¯Ÿãéå°é䜿çšããããšãã§ãã
ããåå¿ã«æªåœ±é¿ãåãŒããªãéããèªç±ã«å€ã
ãããšãã§ããã該ã¢ã³ã¢ãã¢ãããã¯ãã®å¡©
ã¯ã補é æ³ïŒ£ã§äœ¿çšããã¢ã³ã¢ãã¢ãããã¯ãã®
å¡©ãçšããããšãã§ããã æ¬è£œé æ³ã®åå¿æº¶åªãåå¿æž©åºŠãåå¿æéãå
é¢ç²Ÿè£œåŠçã®æäœæ¹æ³ã¯ã補é æ³ïŒ¡ãšåæ§ã«è¡ã
ããšãã§ããã 次ã«ãæ¬çºæã®äžè¬åŒããã®ãžãããããªãž
ã³èªå°äœã補é ããããã®æçšãªäžéäœã§ããäž
è¬åŒããã®ãããã³é žãšã¹ãã«ããã³äžè¬åŒ
ããã®ãããã³é žãšã¹ãã«ã®è£œé æ¹æ³ã«ã€ããŠ
説æããã å ããäžè¬åŒããã®ãããã³é žãšã¹ãã«ã®è£œ
é æ³ã«ã€ããŠèª¬æããã äžè¬åŒããã®ååç©ã¯ããã§ã«å ¬ç¥ã§ãã
ãããŸãã¯äŸãã°M.Mark MidlandïŒJ.Org.
Chem.ã40ã2250â2252ïŒ1975ïŒãHenne
GreenleeïŒJ.Am.Chem.Soc.ã67ã484ïŒ1945ïŒç
ã«èšèŒãããå ¬ç¥ã®æ¹æ³ã«æºããŠåæããããã
ãªãã¡ã åŒ HOâââ¡CH ãåŒäžãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åº
ã瀺ããã§è¡šããããååç©ãšãã¹ã²ã³ãŸãã¯ã
ãªã¯ããã¡ãã«ã¯ãããã«ã¡ãŒããšãåå¿ãã
ãŠã åŒ ClâCOOâââ¡CH ãåŒäžãã¯åèšã®æå³ãæãããã§è¡šãããã
ååç©ãšãããããš åŒ ãåŒäžãR6ããã³R7ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽããã¢ã«ãã«
åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ãã«åºãã¢ã©
ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã瀺ããã§è¡šãããã
ååç©ãšãåå¿ãããŠã åŒ ãåŒäžãR6ãR7ããã³ïŒ¡ã¯åèšã®æå³ãæããã
ã§è¡šããããååç©ãšãã次ãã§ããã«éå±åè©Š
è¬ãäœçšãããŠææ©éå±ååç©ãšããããã« åŒ ClCOOR4 ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºã瀺ããã§è¡šãã
ããååç©ãåå¿ãããããšã«ãããäžè¬åŒ
ããã®ååç©ã¯è£œé ãããã ãŸãäžè¬åŒããã®ååç©ã®ç¬¬ïŒã®è£œé æ³ãšã
ãŠã åŒ HOâââ¡ïŒ£âCOOR4 ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãã¯çŽéç¶ãŸã
ã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããã§è¡šããããå
åç©ãš åŒ R8NCO ãåŒäžãR8ã¯ã¯ããã¹ã«ããã«åºããžã¯ããã¹
ã«ããã«åºãããªã¯ããã¢ã»ãã«åºãäœçŽã¢ã«ã
ã«åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºã
ã·ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºã瀺ããã§è¡šããããã€ãœã·ã¢ããŒããããã¯
åå¿æ¡ä»¶äžã§è©²ã€ãœã·ã¢ããŒããçæããååç©
ãšãåå¿ãããããå¿ èŠã§ããã°ãå æ°Žå解ãã
ããšãæããããã ããã«ã¯ãåŒ HOâââ¡ïŒ£âCOOR4 ãåŒäžãR4ããã³ïŒ¡ã¯åèšã®æå³ãæãããã§
è¡šããããååç©ãš åŒ ãåŒäžãR6ããã³R7ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽããã¢ã«ãã«
åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ãã«åºãã¢ã©
ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã瀺ããã§è¡šãããã
ååç©ãšãåå¿ãããŠãäžè¬åŒããã®ååç©ã
補é ããããšãã§ããã äžè¬åŒããã®ååç©ã¯ãäŸãã°ãK.Bowden
et al.âResearchers on âacetylenic
compoundsâVol.ã(A)The addition of
amines to ethynyl ketonesçã«èšèŒã®æ¹æ³ã«æº
ããŠãäžè¬åŒããã®ååç©ãšã¢ã³ã¢ãã¢ããã
ã¯ãã®å¡©ãšãåå¿ãããããšã«ãã補é ããããš
ãã§ããã 次ã«ãæ¬çºæã®äžè¬åŒããã®ååç©ã®æçšæ§
ã瀺ãããã«ã以äžã®è¬å¹è¬çè©Šéšããã³æ¯æ§è©Š
éšãè¡ã€ãã è¬å¹è¬çè©Šéš ïŒ è©Šéšæ¹æ³ (a) å è¡ç®¡æ¡åŒµäœçš ãŠãµã®æåºå¿èµãçšããŠãã©ã³ã²ã³ãã«ã
ãO.LangendorffïŒPfugers arch.ges.
phisiol.ã61ã291â322ïŒ1895ïŒãæ³ã«ããå
åèæ¡åŒµäœçšã調ã¹ããå è¡ç®¡æ¡åŒµäœçšã®åŒ·
ãã¯å åèè¡æµéã50ïŒ å¢å ããããµã³ãã«
æäžéå³ã¡pl50ã«ããè©äŸ¡ããã (b) æé«è¡å§äœçš çåŸ15ãªãã16é霢ãäœé300gååŸã®é
æ§é«è¡å§çã©ããïŒspontaneous
hypertensive ratïŒSHRïŒãçšãããè¡å§
ã®æž¬å®ã¯ãSHRãäºã45ãªãã50âã§10ãª
ãã20åéå æž©åŸãèªåè¡å§èšé²èšãçšãã
tail plethysmographæ³ã«ããå°Ÿåèã®åçž®
æè¡å§ãé芳è¡çã«æž¬å®ãããäžçŸ€ïŒãªãã
ïŒå¹çšãããè¬ç©ã¯ãããªãšãã¬ã³ã°ãªã³ãŒ
ã«ïŒ£â300ã«æº¶è§£ãã10ãªãã100mgïŒKgçžåœ
éãçµå£æäžãããæé«è¡å§äœçšã¯è¬ç©æäž
åã®è¡å§ã«å¯ŸããŠãåè¬ç©ãæäžåŸåæéã®
è¡å§ã®æžå°ãæå§ïŒ ãšããŠè¡šãããèšç®åŒ
ã¯ã次ã®éãã§ããã æå§ïŒïŒ ïŒïŒæäžåè¡å§ïŒâïŒæäžåŸåæéã®è¡å§
ïŒïŒïŒæäžåè¡å§ïŒÃ100 (c) æ¥æ§æ¯æ§ DMç³»ããŠã¹ïŒ18ãªãã22gïŒãçšããé
èå æäžã«ããã¢ããã»ã¢ã³ãã»ããŠã³æ³ã«
åŸã€ãŠID50å€ãæ±ããã (2) è©Šéšçµæ ã©ã³ã²ã³ãã«ãæ³ã«ãããŠãµã®ã«å¯Ÿããå è¡
管æ¡åŒµäœçšäžŠã³ã«ããŠã¹ã«å¯Ÿããæ¥æ§æ¯æ§ã¯æ¬¡
ã®è¡šâïŒã«ç€ºãéãã§ãã€ãã
ããããªãžã³èªå°äœãããã«è©³ããã¯ãïŒâïŒçœ®
æãŸãã¯ç¡çœ®æã¢ããïŒã«ã«ããã«ãªãã·ã¢ã«ã
ã«âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«
ãã³é žå¯Ÿç§°ãŸãã¯é察称ãžãšã¹ãã«èªå°äœããã®
補é æ³ããã³ãã®çšéã«é¢ããã åŸæ¥æè¡ããã³çºæã解決ããããšããèª²é¡ åŸæ¥ããïŒïŒïŒâãžãããããªãžã³éªšæ Œãæã
ã埪ç°åšå®çšè¬ãšããŠã¯ããããšãžãã³
ïŒNifedipineïŒïŒïŒïŒâãžã¡ãã«ãïŒïŒïŒâãžã¡
ãã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâãžã
ããããªãžã³âïŒïŒïŒâãžã«ã«ããã·ã©ãŒãïŒç±³
åœç¹èš±ç¬¬3485847å·å ¬å ±åç §ïŒãç¥ãããŠããã
ãŸããïŒâïŒçœ®æãŸãã¯ç¡çœ®æã¢ããïŒã«ã«ãã
ã«ãªãã·ã¢ã«ãã«åºãæããïŒïŒïŒâãžãããã
ãªãžã³èªå°äœã¯ãç¹éæ57â118565å·å ¬å ±ããã³
å57â175166å·å ¬å ±çã«é瀺ãããŠãããããã
ãªãããæ¢åã®ïŒïŒïŒâãžãããããªãžã³èªå°äœ
ãæããè¡ç®¡æ¡åŒµäœçšããã³å®å šæ§ã¯ãå åãšã¯
ããããããåªããè¡ç®¡æ¡åŒµäœçšããã³è¡å§éäž
äœçšãæãããã€æ¯æ§ã極ããŠåŒ±ããå»è¬ãšããŠ
æçšãªååç©ãæ±ããããŠããã 課é¡ã解決ããããã®æ段 æ¬çºæè ãã¯ãããåªããè¡ç®¡æ¡åŒµäœçšããã³
è¡å§éäžäœçšãæããå®å šæ§ã«åªããïŒïŒïŒâãž
ãããããªãžã³èªå°äœãåµè£œãã¹ãéæç 究ãã
çµæãïŒïŒïŒâãžãããããªãžã³æ žã®ïŒäœã«ïŒçœ®
æãŸãã¯ç¡çœ®æã¢ããïŒã«ã«ããã«ãªãã·ã¢ã«ã
ã«åºãæãã該ããªãžã³æ žã®ïŒäœããã³ïŒäœã«å¯Ÿ
称ãŸãã¯é称ã®äœçŽã¢ã«ãã«ãªãã·ã«ã«ããã«åº
ãæããæ°èŠãªïŒïŒïŒâãžãããããªãžã³èªå°äœ
ããæ¢åã®ïŒïŒïŒâãžãããããªãžã³èªå°äœã«æ¯
ã¹ãŠãåªããè¡ç®¡æ¡åŒµäœçšãæãããã€æ¯æ§ã匱
ãããšãèŠåºãæ¬çºæãå®æããã æ¬çºæã¯ãäžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠã
ãŠäœçŽã¢ã«ãã«åºãR6ããã³R7ã¯åäžãŸãã¯ç°
ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽã
ãã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ã
ã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãã¯çŽé
ç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããäœãã
R1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã§
ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ããã§
è¡šãããïŒïŒïŒâãžãããããªãžã³èªå°äœããã®
補é æ³ããã³ãã®çšéã«é¢ããã 次ã«ãæ¬æ现æžäžã«èšèŒãããåçš®çšèªã«ã€ã
ãŠèª¬æããã äœçŽã¢ã«ãã«åºãšã¯ãççŽ æ°ïŒãªããïŒåãã
ãªãçŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã«åºã瀺ããäŸ
ãã°ã¡ãã«åºããšãã«åºããããã«åºãã€ãœãã
ãã«åºãããã«åºãã€ãœããã«åºãsecâããã«
åºãtertâããã«åºããã³ãã«åºãããã·ã«åºç
ãæããããã äœçŽã¢ã«ã³ãã·åºãšã¯ãçæ°çŽ ïŒãªããïŒåã
ããªãçŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ã³ãã·åºã瀺
ããäŸãã°ã¡ããã·åºããšããã·åºãããããã·
åºãã€ãœããããã·åºããããã·åºãã€ãœããã
ã·åºãsecâãããã·åºãtertâãããã·åºãã
ã³ãã«ãªãã·åºãããã·ã«ãªãã·åºçãæããã
ãã äœçŽããã¢ã«ãã«åºãšã¯ãåèšã®äœçŽã¢ã«ãã«
åºã«ããã²ã³ååã眮æããããã¢ã«ãã«åºã瀺
ããäŸãã°Î²âã¯ãããšãã«åºãβâããã¢ãšã
ã«åºãβâã¯ãããããã«åºãβïŒÎ²âãžã¯ãã
ãšãã«åºãβïŒÎ²ïŒÎ²âããªã¯ãããšãã«åºçã
æããããã äœçŽã¢ã«ããã«åºãšã¯ãçæ°çŽ ïŒãªããïŒåã
ããªãã¢ã«ããã«åºã瀺ããäŸãã°ãããã«ã®ã«
åºãïŒâãããã«åºçãæããããã ã·ã¯ãã¢ã«ãã«åºãšã¯ãäŸãã°ã·ã¯ããããã«
åºãã·ã¯ãããã«åºãã·ã¯ããã³ãã«åºãã·ã¯ã
ããã·ã«åºãã·ã¯ããããã«åºçãæããããã ãžäœçŽã¢ã«ãã«ã¢ããåºãšã¯ãåèšã®äœçŽã¢ã«
ãã«åºã眮æãããžã¢ã«ãã«ã¢ããåºã瀺ããäŸ
ãã°ãžã¡ãã«ã¢ããåºããžãšãã«ã¢ããåºããšã
ã«ã¡ãã«ã¢ããåºçãæããããã ã¢ã©ã«ãã«åºãšã¯ãäŸãã°ãã³ãžã«åºãããšã
ãã«åºãαâã¡ãã«ãã³ãžã«åºçãæããããã ã¢ãªãŒã«åºãšã¯ãäŸãã°ããšãã«åºããããã«
åºã眮æããšãã«åºïŒäœãããã®çœ®æåºãšããŠ
ã¯ãããã²ã³ååããããåºãäœçŽã¢ã«ãã«åºã
äœçŽã¢ã«ã³ãã·åºããžäœçŽã¢ã«ãã«ã¢ããåºãã
ã³ã·ã¢ãåºçãæããããïŒçãæããããã çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºãšã¯ãçæ°
çŽ ïŒãªããïŒåãããªãã¢ã«ãã¬ã³åºã瀺ããäŸ
ãã°ã¡ãã¬ã³åºããšãã¬ã³åºããããã¬ã³åºãã
ãã©ã¡ãã¬ã³åºãã¡ãã«ã¡ãã¬ã³åºããžã¡ãã«ã¡
ãã¬ã³åºçãæããããã äžè¬åŒããã®ååç©ã«ãããŠãR1ããã³R2
ã¯åäžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãå¡©çŽ åå
ãŸãã¯ãããåºã瀺ããäœããR1ããã³R2ã®ã
ã¥ããäžæ¹ãæ°ŽçŽ ååã®ãšããä»æ¹ã¯å¡©çŽ ååãŸ
ãã¯ãããåºãæå³ãããŸãäžæ¹ããããåºã®ãš
ããä»æ¹ã¯æ°ŽçŽ ååãæå³ãããR1ããã³R2ã
å¡©çŽ ååã§ããååç©ã¯ãè¯å¥œãªè¬ç掻æ§ãæã
ãã ãŸããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠ
ããŠäœçŽã¢ã«ãã«åºã瀺ãããççŽ æ°ïŒãªããïŒ
åã®ã¢ã«ãã«åºãç¹ã«å¥œãŸããã R6ããã³R7ã¯åäžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ
ååãäœçŽã¢ã«ãã«åºãäœçŽããã¢ã«ãã«åºãäœ
çŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«
åºãŸãã¯ã¢ãªãŒã«åºã瀺ããé£æ¥ããçªçŽ ååãš
å ±ã«çœ®æãŸãã¯ç¡çœ®æã®ã¢ããåºã圢æãããäœ
ããR1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœ
çŽã¢ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºã§ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ã
ããããç¹ã«R6ããã³R7ãæ°ŽçŽ ååã®ååç©ã¯ã
è¯å¥œãªè¬ç掻æ§ãæããã 次ã«ãæ¬çºæååç©ã®è£œé æ³ã«ã€ããŠèª¬æã
ãã æ¬çºæã®äžè¬åŒããã®ååç©ã¯ã以äžã®è£œé
æ³ïŒ¡ã補é æ³ïŒ¢ã補é æ³ïŒ£ããã³è£œé æ³ïŒ€ã®ãã
ãã®æ¹æ³ã«ãã€ãŠã補é ããããšãã§ããã 補é æ³ ïŒ¡ æ¬è£œé æ³ã«ããã°ãäžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠããŠäœ
çŽã¢ã«ãã«åºã瀺ããã§è¡šãããååç©ãšãåå¿
ãããããšã«ããäžè¬åŒããã®ååç©ã補é ã
ãããšãã§ããã 補é æ³ ïŒ¢ æ¬è£œé æ³ã«ããã°ãäžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããã§è¡šãããååç©ãš äžè¬åŒãã R5âCOCH2COOR3 ãã ãåŒäžãR3ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠããŠ
äœçŽã¢ã«ãã«åºã瀺ããã§è¡šãããååç©ãšãå
å¿ãããããšã«ãããäžè¬åŒããã®ååç©ã補
é ããããšãã§ããã 補é æ³ ïŒ£ æ¬è£œé æ³ã«ããã°ãäžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããã§è¡šãããååç©ãšã¢ã³ã¢ãã¢ãããã¯ã
ã®å¡©ãšãåå¿ãããããšã«ãããäžè¬åŒããã®
ååç©ã補é ããããšãã§ããã 補é æ³ ïŒ€ æ¬è£œé æ³ã«ããã°ãäžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããã§è¡šãããååç©ãš äžè¬åŒãã R5âCOCH2COOR3 ãã ãåŒäžãR3ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠããŠ
äœçŽã¢ã«ãã«åºã瀺ããã§è¡šãããååç©ãšã¢ã³
ã¢ãã¢ãããã¯ãã®å¡©ãšãåå¿ãããããšã«ã
ããäžè¬åŒããã®ååç©ã補é ããããšãã§ã
ãã 以äžã«ãæ¬çºæã®äžè¬åŒããã®ååç©ã®è£œé
æ³ã«ã€ããŠè©³çŽ°ã«èª¬æããã 補é æ³ ïŒ¡ æ¬è£œé æ³ã¯ãäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãžãªãã³ååç©ãšãåå¿
ãããããšã«ãããäžè¬åŒããã®ååç©ã補é
ãããã®ã§ããã äžè¬åŒããã®ååç©ã補é ããéã®åå¿æ¡ä»¶
ã¯ã䜿çšãããåæååç©ã®çš®é¡ã«ããé©å®éžæ
ãããããéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ã«å¯ŸããŠãäžè¬åŒããã®ãã³ãžãªãã³ååç©
ã®äœ¿çšéã¯åå¿ã«ç¹ã«æªåœ±é¿ãåãŒããªãéãã
èªç±ã«å€ããããšãã§ãããã奜ãŸããã¯ã該ã
ããã³é žãšã¹ãã«ãšã»ãŒçã¢ã«äœ¿çšãããåå¿æº¶
åªãšããŠã¯ãåå¿ã«æªåœ±é¿ãåãŒããªããã®ã§ã
ãã°ç¹ã«éå®ãããªãããæ°ŽãäžæŽ»æ§ææ©æº¶åªãŸ
ãã¯æ°ŽãšäžæŽ»æ§ææ©æº¶åªãšã®æ··å溶åªãæããã
ãã 奜ãŸããåå¿æº¶åªãšããŠã¯ãäŸãã°æ°ŽïŒã¡ã¿ã
ãŒã«ããšã¿ããŒã«ããããããŒã«ãã€ãœãããã
ãŒã«äžŠã³ã«ãã¿ããŒã«çã®ã¢ã«ã³ãŒã«ïŒãžãšãã«
ãšãŒãã«ããšãã«ã¡ãã«ãšãŒãã«äžŠã³ã«ãžã€ãœã
ããã«ãšãŒãã«çã®ãšãŒãã«ïŒãžãªããµã³ããã
ã©ããããã©ã³ãã¢ã»ããããªã«ãã¢ã»ãã³ã
ïŒïŒ®âãžã¡ãã«ãã«ã ã¢ãããé ¢é žãšãã«ãã
ã³ãŒã³ããžã¯ããã¡ã¿ã³ããã³ã¯ãããã«ã çã®
äžæŽ»æ§ææ©æº¶åªããã³æ°Žãšãããã®äžæŽ»æ§ææ©æº¶
åªãšã®æ··å溶åªãæããããã åå¿ã¯ãéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãžãªãã³ååç©ã該åå¿
溶åªã«æº¶è§£ããæ¹æäžã宀枩ãªããå ç±äžã奜ãŸ
ããã¯60ãªãã70âã®å ç±äžã§è¡ããããåå¿æ
éã«ã¯ãç¹ã«éå®ã¯ãªãããåå¿ã¯ïŒãªãã24æ
éã§å®çµããã ãŸãã觊åªãšããŠãé ¢é žãããããªã³é žçã®æ
æ©é žããããªãžã³ãããã©ãžã³ããžã€ãœãããã«
ã¢ãã³çã®ææ©å¡©åºãé©éæ·»å ããããšã«ããã
該åå¿ã¯ä¿é²ãããã æ¬è£œé æ³ã«ããåæãããäžè¬åŒããã®åå
ç©ã¯ãåå¿çµäºåŸãææ©æº¶åªãçšããæœåºåŠçã
ã¢ã«ãããã·ãªã«ã²ã«çã®æ äœãçšããã¯ããã
ã°ã©ãã€ãŒã«ããåé¢ç²Ÿè£œåŠçããã³çµæ¶ååŠç
çã®éåžžã®æ¹æ³ããèŠããã°è©²åŠçãé©å®çµåã
ãŠè¡ãããšã«ãããåé¢ã粟補ãåé¢ããã³æ¡å
ããããšãã§ããã 補é æ³ ïŒ¢ æ¬è£œé æ³ã¯ãäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãºã¢ã«ããããšäžè¬åŒ
ããã®Î²âã±ããšã¹ãã«ååç©ãšãåå¿ããã
ããšã«ãããäžè¬åŒããã®ååç©ã補é ããã
ã®ã§ããã äžè¬åŒããã®ååç©ã補é ããéã®åå¿æ¡ä»¶
ã¯ã䜿çšãããåæååç©ã®çš®é¡ã«ããé©å®éžæ
ãããããéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ã«å¯ŸããŠãäžè¬åŒããã®ãã³ãºã¢ã«ãããã
ãã³äžè¬åŒããã®Î²âã±ããšã¹ãã«ååç©ã®äœ¿
çšéã¯ãåå¿ã«ç¹ã«æªåœ±é¿ãåãŒããªãéããèª
ç±ã«å€ããããšãã§ãããã奜ãŸããã¯è©²ããã
ã³é žãšã¹ãã«ãšå€«ã ã»ãŒçã¢ã«é䜿çšããã æ¬è£œé æ³ã®åå¿æº¶åªãåå¿æž©åºŠãåå¿æéãå
é¢ç²Ÿè£œåŠçã®æäœæ¹æ³ã¯ã補é æ³ïŒ¡ãšåæ§ã«è¡ã
ããšãã§ããã 補é æ³ ïŒ£ æ¬è£œé æ³ã¯ãäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãžãªãã³ååç©ãšã¢ã³ã¢
ãã¢ãããã¯ãã®å¡©ãšãåå¿ãããããšã«ããã
äžè¬åŒããã®ååç©ã補é ãããã®ã§ããã äžè¬åŒããã®ååç©ã補é ããéã®åå¿æ¡ä»¶
ã¯ã䜿çšãããåæååç©ã®çš®é¡ã«ããé©å®éžæ
ãããããéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ã«å¯ŸããŠãäžè¬åŒããã®ãã³ãžãªãã³ååç©
ã®äœ¿çšéã¯åå¿ã«ç¹ã«æªåœ±é¿ãåãŒããªãéãã
èªç±ã«å€ããããšãã§ãããã奜ãŸããã¯è©²ãã
ãã³é žãšã¹ãã«ãšã»ãŒçã¢ã«é䜿çšããããŸãã
ã¢ã³ã¢ãã¢ãããã¯ãã®å¡©ã¯ã該ãããã³é žãšã¹
ãã«ã«å¯Ÿãéå°é䜿çšããããšãã§ããããåå¿
ã«æªåœ±é¿ãåãŒããªãéããèªç±ã«å€ããããšã
ã§ãããã¢ã³ã¢ãã¢ãããã¯ãã®å¡©ãšããŠã¯ãäŸ
ãã°ã¢ã³ã¢ãã¢ïŒè»é žãé ¢é žãé ç³é žãå®æ¯éŠ
é žãããšãã«é ¢é žçã®ææ©é žãšã®ã¢ã³ã¢ããŠã
å¡©ïŒçé žãããŠé žçã®ç¡æ©é žãšã®ã¢ã³ã¢ããŠã å¡©
çãæããããã æ¬è£œé æ³ã®åå¿æº¶åªãåå¿æž©åºŠãåå¿æéãå
é¢ç²Ÿè£œåŠçã®æäœæ¹æ³ã¯ã補é æ³ïŒ¡ãšåæ§ã«è¡ã
ããšãã§ããã 補é æ³ ïŒ€ æ¬è£œé æ³ã¯ãäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ãšäžè¬åŒããã®ãã³ãºã¢ã«ããããšäžè¬åŒ
ããã®Î²âã±ããšã¹ãã«ååç©ãšã¢ã³ã¢ãã¢ã
ããã¯ãã®å¡©ãšãåå¿ãããããšã«ãããäžè¬åŒ
ããã®ååç©ã補é ãããã®ã§ããã äžè¬åŒããã®ååç©ã補é ããéã®åå¿æ¡ä»¶
ã¯ã䜿çšãããåæååç©ã®çš®é¡ã«ããé©å®éžæ
ãããããéåžžäžè¬åŒããã®ãããã³é žãšã¹ã
ã«ã«å¯ŸããŠãäžè¬åŒããã®ãã³ãºã¢ã«ãããã
ãã³äžè¬åŒããã®Î²âã±ããšã¹ãã«ååç©ã®äœ¿
çšéã¯åå¿ã«ç¹ã«æªåœ±é¿ãåãŒããªãéããèªç±
ã«å€ããããšãã§ãããã該ãããã³é žãšã¹ãã«
ãšããããã»ãŒçã¢ã«é䜿çšããã®ã奜ãŸããã
ãŸããã¢ã³ã¢ãã¢ãããã¯ãã®å¡©ã¯ã該ãããã³
é žãšã¹ãã«ã«å¯Ÿãéå°é䜿çšããããšãã§ãã
ããåå¿ã«æªåœ±é¿ãåãŒããªãéããèªç±ã«å€ã
ãããšãã§ããã該ã¢ã³ã¢ãã¢ãããã¯ãã®å¡©
ã¯ã補é æ³ïŒ£ã§äœ¿çšããã¢ã³ã¢ãã¢ãããã¯ãã®
å¡©ãçšããããšãã§ããã æ¬è£œé æ³ã®åå¿æº¶åªãåå¿æž©åºŠãåå¿æéãå
é¢ç²Ÿè£œåŠçã®æäœæ¹æ³ã¯ã補é æ³ïŒ¡ãšåæ§ã«è¡ã
ããšãã§ããã 次ã«ãæ¬çºæã®äžè¬åŒããã®ãžãããããªãž
ã³èªå°äœã補é ããããã®æçšãªäžéäœã§ããäž
è¬åŒããã®ãããã³é žãšã¹ãã«ããã³äžè¬åŒ
ããã®ãããã³é žãšã¹ãã«ã®è£œé æ¹æ³ã«ã€ããŠ
説æããã å ããäžè¬åŒããã®ãããã³é žãšã¹ãã«ã®è£œ
é æ³ã«ã€ããŠèª¬æããã äžè¬åŒããã®ååç©ã¯ããã§ã«å ¬ç¥ã§ãã
ãããŸãã¯äŸãã°M.Mark MidlandïŒJ.Org.
Chem.ã40ã2250â2252ïŒ1975ïŒãHenne
GreenleeïŒJ.Am.Chem.Soc.ã67ã484ïŒ1945ïŒç
ã«èšèŒãããå ¬ç¥ã®æ¹æ³ã«æºããŠåæããããã
ãªãã¡ã åŒ HOâââ¡CH ãåŒäžãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åº
ã瀺ããã§è¡šããããååç©ãšãã¹ã²ã³ãŸãã¯ã
ãªã¯ããã¡ãã«ã¯ãããã«ã¡ãŒããšãåå¿ãã
ãŠã åŒ ClâCOOâââ¡CH ãåŒäžãã¯åèšã®æå³ãæãããã§è¡šãããã
ååç©ãšãããããš åŒ ãåŒäžãR6ããã³R7ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽããã¢ã«ãã«
åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ãã«åºãã¢ã©
ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã瀺ããã§è¡šãããã
ååç©ãšãåå¿ãããŠã åŒ ãåŒäžãR6ãR7ããã³ïŒ¡ã¯åèšã®æå³ãæããã
ã§è¡šããããååç©ãšãã次ãã§ããã«éå±åè©Š
è¬ãäœçšãããŠææ©éå±ååç©ãšããããã« åŒ ClCOOR4 ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºã瀺ããã§è¡šãã
ããååç©ãåå¿ãããããšã«ãããäžè¬åŒ
ããã®ååç©ã¯è£œé ãããã ãŸãäžè¬åŒããã®ååç©ã®ç¬¬ïŒã®è£œé æ³ãšã
ãŠã åŒ HOâââ¡ïŒ£âCOOR4 ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãã¯çŽéç¶ãŸã
ã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããã§è¡šããããå
åç©ãš åŒ R8NCO ãåŒäžãR8ã¯ã¯ããã¹ã«ããã«åºããžã¯ããã¹
ã«ããã«åºãããªã¯ããã¢ã»ãã«åºãäœçŽã¢ã«ã
ã«åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºã
ã·ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºã瀺ããã§è¡šããããã€ãœã·ã¢ããŒããããã¯
åå¿æ¡ä»¶äžã§è©²ã€ãœã·ã¢ããŒããçæããååç©
ãšãåå¿ãããããå¿ èŠã§ããã°ãå æ°Žå解ãã
ããšãæããããã ããã«ã¯ãåŒ HOâââ¡ïŒ£âCOOR4 ãåŒäžãR4ããã³ïŒ¡ã¯åèšã®æå³ãæãããã§
è¡šããããååç©ãš åŒ ãåŒäžãR6ããã³R7ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽããã¢ã«ãã«
åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ãã«åºãã¢ã©
ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã瀺ããã§è¡šãããã
ååç©ãšãåå¿ãããŠãäžè¬åŒããã®ååç©ã
補é ããããšãã§ããã äžè¬åŒããã®ååç©ã¯ãäŸãã°ãK.Bowden
et al.âResearchers on âacetylenic
compoundsâVol.ã(A)The addition of
amines to ethynyl ketonesçã«èšèŒã®æ¹æ³ã«æº
ããŠãäžè¬åŒããã®ååç©ãšã¢ã³ã¢ãã¢ããã
ã¯ãã®å¡©ãšãåå¿ãããããšã«ãã補é ããããš
ãã§ããã 次ã«ãæ¬çºæã®äžè¬åŒããã®ååç©ã®æçšæ§
ã瀺ãããã«ã以äžã®è¬å¹è¬çè©Šéšããã³æ¯æ§è©Š
éšãè¡ã€ãã è¬å¹è¬çè©Šéš ïŒ è©Šéšæ¹æ³ (a) å è¡ç®¡æ¡åŒµäœçš ãŠãµã®æåºå¿èµãçšããŠãã©ã³ã²ã³ãã«ã
ãO.LangendorffïŒPfugers arch.ges.
phisiol.ã61ã291â322ïŒ1895ïŒãæ³ã«ããå
åèæ¡åŒµäœçšã調ã¹ããå è¡ç®¡æ¡åŒµäœçšã®åŒ·
ãã¯å åèè¡æµéã50ïŒ å¢å ããããµã³ãã«
æäžéå³ã¡pl50ã«ããè©äŸ¡ããã (b) æé«è¡å§äœçš çåŸ15ãªãã16é霢ãäœé300gååŸã®é
æ§é«è¡å§çã©ããïŒspontaneous
hypertensive ratïŒSHRïŒãçšãããè¡å§
ã®æž¬å®ã¯ãSHRãäºã45ãªãã50âã§10ãª
ãã20åéå æž©åŸãèªåè¡å§èšé²èšãçšãã
tail plethysmographæ³ã«ããå°Ÿåèã®åçž®
æè¡å§ãé芳è¡çã«æž¬å®ãããäžçŸ€ïŒãªãã
ïŒå¹çšãããè¬ç©ã¯ãããªãšãã¬ã³ã°ãªã³ãŒ
ã«ïŒ£â300ã«æº¶è§£ãã10ãªãã100mgïŒKgçžåœ
éãçµå£æäžãããæé«è¡å§äœçšã¯è¬ç©æäž
åã®è¡å§ã«å¯ŸããŠãåè¬ç©ãæäžåŸåæéã®
è¡å§ã®æžå°ãæå§ïŒ ãšããŠè¡šãããèšç®åŒ
ã¯ã次ã®éãã§ããã æå§ïŒïŒ ïŒïŒæäžåè¡å§ïŒâïŒæäžåŸåæéã®è¡å§
ïŒïŒïŒæäžåè¡å§ïŒÃ100 (c) æ¥æ§æ¯æ§ DMç³»ããŠã¹ïŒ18ãªãã22gïŒãçšããé
èå æäžã«ããã¢ããã»ã¢ã³ãã»ããŠã³æ³ã«
åŸã€ãŠID50å€ãæ±ããã (2) è©Šéšçµæ ã©ã³ã²ã³ãã«ãæ³ã«ãããŠãµã®ã«å¯Ÿããå è¡
管æ¡åŒµäœçšäžŠã³ã«ããŠã¹ã«å¯Ÿããæ¥æ§æ¯æ§ã¯æ¬¡
ã®è¡šâïŒã«ç€ºãéãã§ãã€ãã
ãè¡šã
è¡šâïŒããæãããªããã«ãæ¬çºæã®ååç©
ã¯å è¡ç®¡ã«äœçšããŠåŒ·åãªå ç¶åèæ¡åŒµå¹æã
瀺ããŠããããŸãæ¥æ§æ¯æ§ã¯ãããšãžãã³ã«ã
ãã¹ãŠæããã«è»œæžãããŠããã é«è¡å§çã©ããïŒSHRïŒã«å¯Ÿããæé«è¡å§
äœçšã¯ãè¡šâïŒã«ç€ºãéãã§ãã€ãã
ã¯å è¡ç®¡ã«äœçšããŠåŒ·åãªå ç¶åèæ¡åŒµå¹æã
瀺ããŠããããŸãæ¥æ§æ¯æ§ã¯ãããšãžãã³ã«ã
ãã¹ãŠæããã«è»œæžãããŠããã é«è¡å§çã©ããïŒSHRïŒã«å¯Ÿããæé«è¡å§
äœçšã¯ãè¡šâïŒã«ç€ºãéãã§ãã€ãã
ãè¡šã
è¡šâïŒããæããã®ããã«ãæ¬çºæã®ååç©
ã¯ãé«è¡å§çã©ããïŒSHRïŒã«å¯Ÿãçµå£æäž
ã§åŒ·åãªæé«è¡å§äœçšã瀺ããŠããããŸããæ
äžåŸïŒæéã«ãããŠãæ¬çºæã®ååç©ã¯é¡èãª
æé«è¡å§äœçšã瀺ããŠãããäœçšã®æç¶æ§ã瀺
åããŠããã 以äžã«ç€ºããè¬çå¹æè©ŠéšäžŠã³ã«æ¯æ§è©Šéšã®
çµæãããæ¬çºæã®ååç©ïŒïŒã¯ãè¡ç®¡æ¡åŒµ
äœçšäžŠã³ã«æé«è¡å§äœçšãæããŠãããç¹ã«æ
é«è¡å§äœçšã匷ãäžã€æ¯æ§ã匱ãã®ã§ãé«è¡å§
çãå¿æ©èœäžå šãçå¿çãå¿çæ¢å¡äžŠã³ã«è³è¡
管é害ãªã©ã®åŸªç°åšç³»çŸç ã®æ²»çå€ãšããŠæåŸ
ãããå»è¬åã§ããã æ¬çºæã®ååç©ïŒïŒã®æäžåœ¢æ ãšããŠã¯ã
äžè¬ã«éèå ãç®äžãŸãã¯çèå 泚å°ããŸãã¯
çŽè žæäžãªã©ã®éçµå£æäžããããã¯é å€ãæ£
å€ãé¡ç²å€ãã«ãã»ã«å€ãèäžé ãŸãã¯ã·ãã
ãå€ãªã©ã®çµå£æäžãªã©ãæããããæäžéãš
ããŠã¯ãæ£è ã®çç¶ã幎什ãäœé䞊ã³ã«æäžåœ¢
æ ã«ãã€ãŠç°ãããéåžžã¯æ人ã«å¯ŸããŠïŒæ¥é
0.1ãªãã1000mgã奜ãŸããã¯ïŒãªã100mgã§ã
ããäžèšã®å補å€ã¯ãããããåšç¥ã®æ¹æ³ã«ã
ã補é ããããšãã§ããã 次ã«æ¬çºæã®è£œé æ³ãå®æœäŸãæããŠè©³ãã説
æããããæ¬çºæã¯ããã«ããç¹ã«éå®ãããã
ã®ã§ã¯ãªãã æ¬çºææ¹æ³ å®æœäŸ ïŒ ïŒâã«ã«ãã¢ã€ã«ãªãã·âïŒâã¢ããã¯ããã³
é žãšãã«9.4gïŒ50ããªã¢ã«ïŒããã³ïŒâïŒïŒïŒïŒâ
ãžã¯ãã«ãã³ãžãªãã³ïŒã¢ã»ãé ¢é žãšãã«14.4g
ïŒ50ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200mlïŒã«æº¶è§£ãã
60ã70âã«ãããŠ16æéæ¹æããŠåå¿ãããåå¿
æ··åç©ãæžå§æ¿çž®ããæ®æž£ãé ¢é žãšãã«âãããµ
ã³ããçµæ¶åãããšçµæ¶ç¶ã®ïŒâïŒïŒïŒïŒâãžã¯
ãã«ããšãã«ïŒâïŒâã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«
âïŒâã¡ãã«âïŒïŒïŒâãžãããããªãžã³âïŒïŒ
ïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«13.3gïŒåç
58.2ïŒ ïŒãåŸãã mpïŒ168â169.5â UVïŒÎ»MeOH naxã236ã360nm IRïŒKBrïŒïŒ3340ã3000ã1675ã1640ã1600ã
1480ã1400ã1385ã1365ã1330ã1275ã1200ã
1120ã1100ã1075ã1040ã795ã780ã735cm-1ã NMRïŒ90MHzãDMSOâd6ïŒïŒÎŽ1.08ïŒïœãïŒ
ïŒHzã6HïŒã227ïŒïœã3HïŒã4.0ïŒïœãïŒïŒ
Hzã4HïŒã4.83ïŒïœãïŒ12Hzã1HïŒã5.07ïŒïœã
ïŒ12Hzã1HïŒã5.38ïŒïœã1HïŒã6.66ïŒïœã
2HïŒã7.04ã7.54ïŒïœã3HïŒã8.83ïŒïœã1HïŒã å®æœäŸ ïŒã19 å®æœäŸïŒã«èšèŒã®æ¹æ³ã«æºæ ããŠè¡šâïŒã«èšèŒ
ãããååç©ãåŸãããã
ã¯ãé«è¡å§çã©ããïŒSHRïŒã«å¯Ÿãçµå£æäž
ã§åŒ·åãªæé«è¡å§äœçšã瀺ããŠããããŸããæ
äžåŸïŒæéã«ãããŠãæ¬çºæã®ååç©ã¯é¡èãª
æé«è¡å§äœçšã瀺ããŠãããäœçšã®æç¶æ§ã瀺
åããŠããã 以äžã«ç€ºããè¬çå¹æè©ŠéšäžŠã³ã«æ¯æ§è©Šéšã®
çµæãããæ¬çºæã®ååç©ïŒïŒã¯ãè¡ç®¡æ¡åŒµ
äœçšäžŠã³ã«æé«è¡å§äœçšãæããŠãããç¹ã«æ
é«è¡å§äœçšã匷ãäžã€æ¯æ§ã匱ãã®ã§ãé«è¡å§
çãå¿æ©èœäžå šãçå¿çãå¿çæ¢å¡äžŠã³ã«è³è¡
管é害ãªã©ã®åŸªç°åšç³»çŸç ã®æ²»çå€ãšããŠæåŸ
ãããå»è¬åã§ããã æ¬çºæã®ååç©ïŒïŒã®æäžåœ¢æ ãšããŠã¯ã
äžè¬ã«éèå ãç®äžãŸãã¯çèå 泚å°ããŸãã¯
çŽè žæäžãªã©ã®éçµå£æäžããããã¯é å€ãæ£
å€ãé¡ç²å€ãã«ãã»ã«å€ãèäžé ãŸãã¯ã·ãã
ãå€ãªã©ã®çµå£æäžãªã©ãæããããæäžéãš
ããŠã¯ãæ£è ã®çç¶ã幎什ãäœé䞊ã³ã«æäžåœ¢
æ ã«ãã€ãŠç°ãããéåžžã¯æ人ã«å¯ŸããŠïŒæ¥é
0.1ãªãã1000mgã奜ãŸããã¯ïŒãªã100mgã§ã
ããäžèšã®å補å€ã¯ãããããåšç¥ã®æ¹æ³ã«ã
ã補é ããããšãã§ããã 次ã«æ¬çºæã®è£œé æ³ãå®æœäŸãæããŠè©³ãã説
æããããæ¬çºæã¯ããã«ããç¹ã«éå®ãããã
ã®ã§ã¯ãªãã æ¬çºææ¹æ³ å®æœäŸ ïŒ ïŒâã«ã«ãã¢ã€ã«ãªãã·âïŒâã¢ããã¯ããã³
é žãšãã«9.4gïŒ50ããªã¢ã«ïŒããã³ïŒâïŒïŒïŒïŒâ
ãžã¯ãã«ãã³ãžãªãã³ïŒã¢ã»ãé ¢é žãšãã«14.4g
ïŒ50ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200mlïŒã«æº¶è§£ãã
60ã70âã«ãããŠ16æéæ¹æããŠåå¿ãããåå¿
æ··åç©ãæžå§æ¿çž®ããæ®æž£ãé ¢é žãšãã«âãããµ
ã³ããçµæ¶åãããšçµæ¶ç¶ã®ïŒâïŒïŒïŒïŒâãžã¯
ãã«ããšãã«ïŒâïŒâã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«
âïŒâã¡ãã«âïŒïŒïŒâãžãããããªãžã³âïŒïŒ
ïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«13.3gïŒåç
58.2ïŒ ïŒãåŸãã mpïŒ168â169.5â UVïŒÎ»MeOH naxã236ã360nm IRïŒKBrïŒïŒ3340ã3000ã1675ã1640ã1600ã
1480ã1400ã1385ã1365ã1330ã1275ã1200ã
1120ã1100ã1075ã1040ã795ã780ã735cm-1ã NMRïŒ90MHzãDMSOâd6ïŒïŒÎŽ1.08ïŒïœãïŒ
ïŒHzã6HïŒã227ïŒïœã3HïŒã4.0ïŒïœãïŒïŒ
Hzã4HïŒã4.83ïŒïœãïŒ12Hzã1HïŒã5.07ïŒïœã
ïŒ12Hzã1HïŒã5.38ïŒïœã1HïŒã6.66ïŒïœã
2HïŒã7.04ã7.54ïŒïœã3HïŒã8.83ïŒïœã1HïŒã å®æœäŸ ïŒã19 å®æœäŸïŒã«èšèŒã®æ¹æ³ã«æºæ ããŠè¡šâïŒã«èšèŒ
ãããååç©ãåŸãããã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
å®æœäŸ 20
ïŒââã¡ãã«ã«ã«ãã¢ã€ã«ãªãã·âïŒâã¢ã
ãã¯ããã³é žãšãã«10.1gïŒ50ããªã¢ã«ïŒããã³ïŒ
âïŒïŒïŒïŒâãžã¯ãã«ãã³ãžãªãã³ïŒã¢ã»ãé ¢é ž
ãšãã«14.4gïŒ50ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200mlïŒ
ã«æº¶è§£ãã60ã70âã«ãããŠ16æéæ¹æããŠåå¿
ãããåå¿æ··åç©ãæžå§æ¿çž®ããæ®æž£ããžã€ãœã
ããã«ãšãŒãã«âãããµã³ããçµæ¶åãããšçµæ¶
ç¶ã®ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒââ
ã¡ãã«ã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«âïŒâã¡ãã«â
ïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³
é žãžãšãã«ãšã¹ãã«14.4gïŒåç61.1ïŒ ïŒãåŸãã
ãã mpïŒ110â UVïŒÎ»MeOH naxã237ã360nm IRïŒKBrïŒïŒ3375ã3325ã3000ã1680ã1640ã
1550ã1480ã1420ã1280ã1250ã1200ã1120ã
1100ã1050ã865ã780ã740cm-1ã NMRïŒ90MHzãDMSOâd6ïŒïŒÎŽ1.08ïŒïœãïŒ
ïŒHzã6HïŒã228ïŒïœã3HïŒã26ïŒïœãïŒ4.5
Hzã3HïŒã4.0ïŒïœãïŒïŒHzã4HïŒã4.9ïŒïœã
ïŒ13Hzã1HïŒã5.05ïŒïœãïŒ13Hzã1HïŒã
5.38ïŒïœã1HïŒã6.92ã7.28ïŒïœã1HïŒã7.15ïŒïœã
3HïŒã8.83ïŒïœã1HïŒã å®æœäŸ 21ã28 å®æœäŸ20ã«èšèŒã®æ¹æ³ã«æºæ ããŠè¡šâïŒã«èšèŒ
ãããååç©ãåŸãããã
ãã¯ããã³é žãšãã«10.1gïŒ50ããªã¢ã«ïŒããã³ïŒ
âïŒïŒïŒïŒâãžã¯ãã«ãã³ãžãªãã³ïŒã¢ã»ãé ¢é ž
ãšãã«14.4gïŒ50ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200mlïŒ
ã«æº¶è§£ãã60ã70âã«ãããŠ16æéæ¹æããŠåå¿
ãããåå¿æ··åç©ãæžå§æ¿çž®ããæ®æž£ããžã€ãœã
ããã«ãšãŒãã«âãããµã³ããçµæ¶åãããšçµæ¶
ç¶ã®ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒââ
ã¡ãã«ã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«âïŒâã¡ãã«â
ïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³
é žãžãšãã«ãšã¹ãã«14.4gïŒåç61.1ïŒ ïŒãåŸãã
ãã mpïŒ110â UVïŒÎ»MeOH naxã237ã360nm IRïŒKBrïŒïŒ3375ã3325ã3000ã1680ã1640ã
1550ã1480ã1420ã1280ã1250ã1200ã1120ã
1100ã1050ã865ã780ã740cm-1ã NMRïŒ90MHzãDMSOâd6ïŒïŒÎŽ1.08ïŒïœãïŒ
ïŒHzã6HïŒã228ïŒïœã3HïŒã26ïŒïœãïŒ4.5
Hzã3HïŒã4.0ïŒïœãïŒïŒHzã4HïŒã4.9ïŒïœã
ïŒ13Hzã1HïŒã5.05ïŒïœãïŒ13Hzã1HïŒã
5.38ïŒïœã1HïŒã6.92ã7.28ïŒïœã1HïŒã7.15ïŒïœã
3HïŒã8.83ïŒïœã1HïŒã å®æœäŸ 21ã28 å®æœäŸ20ã«èšèŒã®æ¹æ³ã«æºæ ããŠè¡šâïŒã«èšèŒ
ãããååç©ãåŸãããã
ãè¡šã
ãè¡šã
ãè¡šã
å®æœäŸ 29
ïŒâïŒïŒ®âãžã¡ãã«ã«ã«ãã¢ã€ã«ãªãã·âïŒ
âã¢ããã¯ããã³é žãšãã«10.8gïŒ50ããªã¢ã«ïŒã
ãã³ïŒâïŒïŒâããããã³ãžãªãã³ïŒã¢ã»ãé ¢é ž
ãšãã«13.2gïŒ50ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200mlïŒ
ã«æº¶è§£ãã70ã80âã«ãããŠ16æéæ¹æããŠåå¿
ãããåå¿æ··åç©ãæžå§æ¿çž®ããæ®æž£ããžã€ãœã
ããã«ãšãŒãã«âãããµã³ããçµæ¶åãããšçµæ¶
ç¶ã®ïŒâïŒïŒâãããããšãã«ïŒâïŒâïŒïŒ®âãž
ã¡ãã«ã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«âïŒâã¡ãã«â
ïŒïŒïŒâãžãããããªãžã³âãžã«ã«ãã³é žãžãšã
ã«ãšã¹ãã«16.4gïŒåç71.1ïŒ ïŒãåŸãããã mpïŒ131ã131.5â UVïŒÎ»MeOH nax237ã356nm IRïŒKBrïŒïŒ3220ã2990ã1680ã1495ã1445ã
1345ã1280ã1200ã1100ã1060ã1120ã905ã
760ã715cm-1ã NMRïŒ90MHzãDMSOâd6ïŒïŒ0.98ã1.33ïŒïœã
6HïŒã233ïŒïœã3HïŒã288ïŒïœã6HïŒã4.06ïŒïœã
ïŒïŒHzã4HïŒã5.0ïŒïœãïŒ12Hzã1HïŒã
5.07ïŒïœã1HïŒã5.14ïŒïœãïŒ12Hzã1HïŒã
7.46ã8.18ïŒïœã4HïŒã9.15ïŒïœã1HïŒã å®æœäŸ 30ã44 å®æœäŸ29ã«èšèŒã®æ¹æ³ã«æºæ ããŠãè¡šâïŒã«èš
èŒãããååç©ãåŸãããã
âã¢ããã¯ããã³é žãšãã«10.8gïŒ50ããªã¢ã«ïŒã
ãã³ïŒâïŒïŒâããããã³ãžãªãã³ïŒã¢ã»ãé ¢é ž
ãšãã«13.2gïŒ50ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200mlïŒ
ã«æº¶è§£ãã70ã80âã«ãããŠ16æéæ¹æããŠåå¿
ãããåå¿æ··åç©ãæžå§æ¿çž®ããæ®æž£ããžã€ãœã
ããã«ãšãŒãã«âãããµã³ããçµæ¶åãããšçµæ¶
ç¶ã®ïŒâïŒïŒâãããããšãã«ïŒâïŒâïŒïŒ®âãž
ã¡ãã«ã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«âïŒâã¡ãã«â
ïŒïŒïŒâãžãããããªãžã³âãžã«ã«ãã³é žãžãšã
ã«ãšã¹ãã«16.4gïŒåç71.1ïŒ ïŒãåŸãããã mpïŒ131ã131.5â UVïŒÎ»MeOH nax237ã356nm IRïŒKBrïŒïŒ3220ã2990ã1680ã1495ã1445ã
1345ã1280ã1200ã1100ã1060ã1120ã905ã
760ã715cm-1ã NMRïŒ90MHzãDMSOâd6ïŒïŒ0.98ã1.33ïŒïœã
6HïŒã233ïŒïœã3HïŒã288ïŒïœã6HïŒã4.06ïŒïœã
ïŒïŒHzã4HïŒã5.0ïŒïœãïŒ12Hzã1HïŒã
5.07ïŒïœã1HïŒã5.14ïŒïœãïŒ12Hzã1HïŒã
7.46ã8.18ïŒïœã4HïŒã9.15ïŒïœã1HïŒã å®æœäŸ 30ã44 å®æœäŸ29ã«èšèŒã®æ¹æ³ã«æºæ ããŠãè¡šâïŒã«èš
èŒãããååç©ãåŸãããã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
å®æœäŸ 45
ïŒâã«ã«ãã¢ã€ã«ãªãã·âïŒâã¢ããã¯ããã³
é žãšãã«9.4gïŒ50ããªã¢ã«ïŒãïŒïŒïŒâãžã¯ãã«ã
ã³ãºã¢ã«ããã8.75gïŒ50ããªã¢ã«ïŒäžŠã³ã«ã¢ã»ã
é ¢é žãšãã«6.5gïŒ50ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200
mlïŒã«æº¶è§£ãã60ã70âã16æéæ¹æããŠåå¿ã
ããåå¿æ··åç©ãæžå§æ¿çž®ããæ®æž£ãé ¢é žãšãã«
âãããµã³ããçµæ¶åãããšçµæ¶ç¶ã®ïŒâïŒïŒïŒ
ïŒâãžã¯ãã«ããšãã«ïŒâïŒâã«ã«ãã¢ã€ã«ãªã
ã·ã¡ãã«âïŒâã¡ãã«âïŒïŒïŒâãžãããããªãž
ã³âïŒïŒïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«8.7g
ïŒåç38.0ïŒ ïŒãåŸãã mpïŒ168ã169.5â ãã®ãã®ã®UVãIR䞊ã³ã«NMRã®æ©åšåæã
ãŒã¿ã¯å®æœäŸïŒã®çæç©ã®ãããšããäžèŽã瀺ã
ãã å®æœäŸ 46 ïŒâã«ã«ãã¢ã€ã«ãªãã·ããããŒã«é žãšãã«
8.6gïŒ50ããªã¢ã«ïŒãïŒâïŒïŒïŒïŒâãžã¯ãã«ãã³
ãžãªãã³ïŒã¢ã»ãé ¢é žãšãã«14.4gïŒ50ããªã¢ã«ïŒ
䞊ã³ã«é ¢é žã¢ã³ã¢ããŠã 10gïŒ125ããªã¢ã«ïŒããš
ã¿ããŒã«ïŒ200mlïŒã«æº¶è§£ãã60ã70âã16æé
æ¹æããŠåå¿ãããåå¿æ··åç©ãæžå§æ¿çž®ããæ²¹
ç¶æ®æž£ãé ¢é žãšãã«ïŒ200mlïŒã§æœåºåŠçããã
é ¢é žãšãã«æœåºæ¶²ãç¡æ°Žç¡«é žãã°ãã·ãŠã ã§è±æ°Ž
åŠçããæžå§æ¿çž®ãããæ®æž£ãåå液äœã¯ããã
ã°ã©ãè£ çœ®ïŒãŠãªãŒã¿ãŒãºç€Ÿãã·ã¹ãã 500AïŒ
ã«ããPrep PAkâ500ïŒSILICAã®ã«ã©ã ãçšã
é ¢é žãšãã«âãããµã³ïŒïŒïŒïŒïŒãå±éããŠåé¢
粟補åŠçãããæå¹ç»åãéãæžå§æ¿çž®ããæ®æž£
ããžã€ãœãããã«ãšãŒãã«âãããµã³ããçµæ¶å
ãããšçµæ¶ç¶ã®ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒ
âïŒâã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«âïŒâã¡ãã«â
ïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³
é žãžãšãã«ãšã¹ãã«5.6gïŒåç24.5ïŒ ïŒãåŸãã mpïŒ168ã169.5â ãã®ãã®ã®UVãIR䞊ã³ã«NMRã®æ©åšåæã
ãŒã¿ã¯å®æœäŸïŒã®çæç©ã®ãããšããäžèŽã瀺ã
ãã å®æœäŸ 47 ïŒâã«ã«ãã¢ã€ã«ãªãã·ããããŒã«é žãšãã«
8.6gïŒ50ããªã¢ã«ïŒãïŒïŒïŒâãžã¯ãã«ãã³ãžãªã
ã³ã¢ã«ããã8.75gïŒ50ããªã¢ã«ïŒãã¢ã»ãé ¢é žãš
ãã«6.4gïŒ50ããªã¢ã«ïŒäžŠã³ã«é ¢é žã¢ã³ã¢ããŠã
10gïŒ125ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200mlïŒã«æº¶
解ãã60ã70âã16æéæ¹æããŠåå¿ãããåå¿
æ··åç©ãæžå§æ¿çž®ããæ®æž£ãé ¢é žãšãã«ïŒ200mlïŒ
ã§æœåºåŠçãããæœåºæ¶²ãç¡æ°Žç¡«é žãã°ãã·ãŠã
ã§è±æ°ŽåŠçããããšæžå§æ¿çž®ãããæ®æž£ãåå液
äœã¯ãããã°ã©ãè£ çœ®ïŒãŠãªãŒã¿ãŒãºç€Ÿãã·ã¹ã
ã 500AïŒã«ããPrep PAkâ500ïŒSILICAã®ã«
ã©ã äžãé ¢é žãšãã«âãããµã³ïŒïŒïŒïŒïŒãå±é
ããŠãåé¢ç²Ÿè£œåŠçãããæå¹ç»åãéãæžå§æ¿
çž®ããæ®æž£ããžã€ãœãããã«ãšãŒãã«âãããµã³
ããçµæ¶åãããšçµæ¶ç¶ã®ïŒâïŒïŒïŒïŒâãžã¯ã
ã«ããšãã«ïŒâïŒâã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«â
ïŒâã¡ãã«âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒ
âãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«4.8gïŒåç21.0
ïŒ ïŒãåŸãã mpïŒ168ã169.5â ãã®ãã®ã®UVãIR䞊ã³ã«NMRã®æ©åšåæã
ãŒã¿ã¯å®æœäŸïŒã®çæç©ã®ãããšããäžèŽã瀺ã
ãã çºæã®å¹æ æ¬çºæã®äžè¬åŒããã®ååç©ã¯è¡ç®¡æ¡åŒµäœçš
ããã³è¡å§éäžäœçšãæããç¹ã«å è¡ç®¡æ¡åŒµäœçš
ã匷ãããã€æ¯æ§ã極ããŠåŒ±ãã®ã§ãé«è¡å§çã
å¿æ©èœäžå šãçå¿çããã³å¿çæ¢å¡çã®åŸªç°åšç³»
çŸæã®æ²»çã«æçšã§ãããšæåŸ ãããã
é žãšãã«9.4gïŒ50ããªã¢ã«ïŒãïŒïŒïŒâãžã¯ãã«ã
ã³ãºã¢ã«ããã8.75gïŒ50ããªã¢ã«ïŒäžŠã³ã«ã¢ã»ã
é ¢é žãšãã«6.5gïŒ50ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200
mlïŒã«æº¶è§£ãã60ã70âã16æéæ¹æããŠåå¿ã
ããåå¿æ··åç©ãæžå§æ¿çž®ããæ®æž£ãé ¢é žãšãã«
âãããµã³ããçµæ¶åãããšçµæ¶ç¶ã®ïŒâïŒïŒïŒ
ïŒâãžã¯ãã«ããšãã«ïŒâïŒâã«ã«ãã¢ã€ã«ãªã
ã·ã¡ãã«âïŒâã¡ãã«âïŒïŒïŒâãžãããããªãž
ã³âïŒïŒïŒâãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«8.7g
ïŒåç38.0ïŒ ïŒãåŸãã mpïŒ168ã169.5â ãã®ãã®ã®UVãIR䞊ã³ã«NMRã®æ©åšåæã
ãŒã¿ã¯å®æœäŸïŒã®çæç©ã®ãããšããäžèŽã瀺ã
ãã å®æœäŸ 46 ïŒâã«ã«ãã¢ã€ã«ãªãã·ããããŒã«é žãšãã«
8.6gïŒ50ããªã¢ã«ïŒãïŒâïŒïŒïŒïŒâãžã¯ãã«ãã³
ãžãªãã³ïŒã¢ã»ãé ¢é žãšãã«14.4gïŒ50ããªã¢ã«ïŒ
䞊ã³ã«é ¢é žã¢ã³ã¢ããŠã 10gïŒ125ããªã¢ã«ïŒããš
ã¿ããŒã«ïŒ200mlïŒã«æº¶è§£ãã60ã70âã16æé
æ¹æããŠåå¿ãããåå¿æ··åç©ãæžå§æ¿çž®ããæ²¹
ç¶æ®æž£ãé ¢é žãšãã«ïŒ200mlïŒã§æœåºåŠçããã
é ¢é žãšãã«æœåºæ¶²ãç¡æ°Žç¡«é žãã°ãã·ãŠã ã§è±æ°Ž
åŠçããæžå§æ¿çž®ãããæ®æž£ãåå液äœã¯ããã
ã°ã©ãè£ çœ®ïŒãŠãªãŒã¿ãŒãºç€Ÿãã·ã¹ãã 500AïŒ
ã«ããPrep PAkâ500ïŒSILICAã®ã«ã©ã ãçšã
é ¢é žãšãã«âãããµã³ïŒïŒïŒïŒïŒãå±éããŠåé¢
粟補åŠçãããæå¹ç»åãéãæžå§æ¿çž®ããæ®æž£
ããžã€ãœãããã«ãšãŒãã«âãããµã³ããçµæ¶å
ãããšçµæ¶ç¶ã®ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒ
âïŒâã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«âïŒâã¡ãã«â
ïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³
é žãžãšãã«ãšã¹ãã«5.6gïŒåç24.5ïŒ ïŒãåŸãã mpïŒ168ã169.5â ãã®ãã®ã®UVãIR䞊ã³ã«NMRã®æ©åšåæã
ãŒã¿ã¯å®æœäŸïŒã®çæç©ã®ãããšããäžèŽã瀺ã
ãã å®æœäŸ 47 ïŒâã«ã«ãã¢ã€ã«ãªãã·ããããŒã«é žãšãã«
8.6gïŒ50ããªã¢ã«ïŒãïŒïŒïŒâãžã¯ãã«ãã³ãžãªã
ã³ã¢ã«ããã8.75gïŒ50ããªã¢ã«ïŒãã¢ã»ãé ¢é žãš
ãã«6.4gïŒ50ããªã¢ã«ïŒäžŠã³ã«é ¢é žã¢ã³ã¢ããŠã
10gïŒ125ããªã¢ã«ïŒããšã¿ããŒã«ïŒ200mlïŒã«æº¶
解ãã60ã70âã16æéæ¹æããŠåå¿ãããåå¿
æ··åç©ãæžå§æ¿çž®ããæ®æž£ãé ¢é žãšãã«ïŒ200mlïŒ
ã§æœåºåŠçãããæœåºæ¶²ãç¡æ°Žç¡«é žãã°ãã·ãŠã
ã§è±æ°ŽåŠçããããšæžå§æ¿çž®ãããæ®æž£ãåå液
äœã¯ãããã°ã©ãè£ çœ®ïŒãŠãªãŒã¿ãŒãºç€Ÿãã·ã¹ã
ã 500AïŒã«ããPrep PAkâ500ïŒSILICAã®ã«
ã©ã äžãé ¢é žãšãã«âãããµã³ïŒïŒïŒïŒïŒãå±é
ããŠãåé¢ç²Ÿè£œåŠçãããæå¹ç»åãéãæžå§æ¿
çž®ããæ®æž£ããžã€ãœãããã«ãšãŒãã«âãããµã³
ããçµæ¶åãããšçµæ¶ç¶ã®ïŒâïŒïŒïŒïŒâãžã¯ã
ã«ããšãã«ïŒâïŒâã«ã«ãã¢ã€ã«ãªãã·ã¡ãã«â
ïŒâã¡ãã«âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒ
âãžã«ã«ãã³é žãžãšãã«ãšã¹ãã«4.8gïŒåç21.0
ïŒ ïŒãåŸãã mpïŒ168ã169.5â ãã®ãã®ã®UVãIR䞊ã³ã«NMRã®æ©åšåæã
ãŒã¿ã¯å®æœäŸïŒã®çæç©ã®ãããšããäžèŽã瀺ã
ãã çºæã®å¹æ æ¬çºæã®äžè¬åŒããã®ååç©ã¯è¡ç®¡æ¡åŒµäœçš
ããã³è¡å§éäžäœçšãæããç¹ã«å è¡ç®¡æ¡åŒµäœçš
ã匷ãããã€æ¯æ§ã極ããŠåŒ±ãã®ã§ãé«è¡å§çã
å¿æ©èœäžå šãçå¿çããã³å¿çæ¢å¡çã®åŸªç°åšç³»
çŸæã®æ²»çã«æçšã§ãããšæåŸ ãããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠã
ãŠäœçŽã¢ã«ãã«åºãR6ããã³R7ã¯åäžãŸãã¯ç°
ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽã
ãã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ã
ã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãã¯çŽé
ç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããäœãã
R1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã§
ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ããã§
è¡šãããïŒïŒïŒâãžãããããªãžã³èªå°äœã ïŒ äžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠããŠäœ
çŽã¢ã«ãã«åºã瀺ããã§è¡šãããååç©ãšãåå¿
ãããããšãç¹åŸŽãšããã äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠã
ãŠäœçŽã¢ã«ãã«åºãR6ããã³R7ã¯åäžãŸãã¯ç°
ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽã
ãã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ã
ã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãã¯çŽé
ç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããäœãã
R1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã§
ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ããã§
è¡šãããïŒïŒïŒâãžãããããªãžã³èªå°äœã®è£œé
æ³ã ïŒ äžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããã§è¡šãããååç©ãš äžè¬åŒãã R5âCOCH2COOR3 ãã ãåŒäžãR3ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠããŠ
äœçŽã¢ã«ãã«åºã瀺ããã§è¡šãããååç©ãšãå
å¿ãããããšãç¹åŸŽãšããã äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠã
ãŠäœçŽã¢ã«ãã«åºãR6ããã³R7ã¯åäžãŸãã¯ç°
ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽã
ãã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ã
ã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãã¯çŽé
ç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããäœãã
R1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã§
ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ããã§
è¡šãããïŒïŒïŒâãžãããããªãžã³èªå°äœã®è£œé
æ³ã ïŒ äžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ãŸãã¯R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããã§è¡šãããååç©ãšã¢ã³ã¢ãã¢ãããã¯ã
ã®å¡©ãšãåå¿ãããããšãç¹åŸŽãšããã äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠã
ãŠäœçŽã¢ã«ãã«åºãR6ããã³R7ã¯åäžãŸãã¯ç°
ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽã
ãã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ã
ã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãã¯çŽé
ç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããäœãã
R1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã§
ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ããã§
è¡šãããïŒïŒïŒâãžãããããªãžã³èªå°äœã®è£œé
æ³ã ïŒ äžè¬åŒãã ãåŒäžãR4ã¯äœçŽã¢ã«ãã«åºãR6ããã³R7ã¯å
äžãŸãã¯ç°ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãäœçŽããã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·
ã¯ãã¢ã«ãã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«
åºãã¯çŽéç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺
ããäœããR6ãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãã·
ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãR7ãæ°ŽçŽ å
åã§ããããã€åŸèšäžè¬åŒããã®ååç©ã«ãã
ãŠãR1ããã³R2ãæ°ŽçŽ ååã§ããå Žåã¯é€ãã
ã§è¡šãããååç©ãš äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããã§è¡šãããååç©ãš äžè¬åŒãã R5âCOCH2COOR3 ãã ãåŒäžãR3ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠããŠ
äœçŽã¢ã«ãã«åºã瀺ããã§è¡šãããååç©ãšã¢ã³
ã¢ãã¢ãããã¯ãã®å¡©ãšãåå¿ãããããšãç¹åŸŽ
ãšããã äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠã
ãŠäœçŽã¢ã«ãã«åºãR6ããã³R7ã¯åäžãŸãã¯ç°
ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽã
ãã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ã
ã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãã¯çŽé
ç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããäœãã
R1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã§
ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ããã§
è¡šãããïŒïŒïŒâãžãããããªãžã³èªå°äœã®è£œé
æ³ã ïŒ äžè¬åŒãã ãåŒäžãR1ããã³R2ã¯åäžãŸãã¯ç°ãªã€ãŠããŠã
æ°ŽçŽ ååãå¡©çŽ ååãŸãã¯ãããåºã瀺ããäœ
ããR1ããã³R2ã®ãã¥ããäžæ¹ãæ°ŽçŽ ååã®ãš
ããä»æ¹ã¯å¡©çŽ ååãŸãã¯ãããåºãæå³ãããŸ
ãäžæ¹ããããåºã®ãšããä»æ¹ã¯æ°ŽçŽ ååãæå³
ãããR3ãR4ããã³R5ã¯åäžãŸãã¯ç°ãªã€ãŠã
ãŠäœçŽã¢ã«ãã«åºãR6ããã³R7ã¯åäžãŸãã¯ç°
ãªã€ãŠããŠãæ°ŽçŽ ååãäœçŽã¢ã«ãã«åºãäœçŽã
ãã¢ã«ãã«åºãäœçŽã¢ã«ããã«åºãã·ã¯ãã¢ã«ã
ã«åºãã¢ã©ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºãã¯çŽé
ç¶ãŸãã¯åå²ç¶ã®ã¢ã«ãã¬ã³åºã瀺ããäœãã
R1ãŸãã¯R2ãæ°ŽçŽ ååãR6ãæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãã·ã¯ãã¢ã«ãã«åºãŸãã¯ã¢ãªãŒã«åºã§
ããããã€R7ãæ°ŽçŽ ååã§ããå Žåã¯é€ããã§
è¡šãããïŒïŒïŒâãžãããããªãžã³èªå°äœãæå¹
æåãšããè¡å§éäžå€ã
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2282883A JPS59152373A (ja) | 1983-02-16 | 1983-02-16 | ïŒïŒïŒâãžãããããªãžã³èªå°äœ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2282883A JPS59152373A (ja) | 1983-02-16 | 1983-02-16 | ïŒïŒïŒâãžãããããªãžã³èªå°äœ |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59152373A JPS59152373A (ja) | 1984-08-31 |
JPH0155268B2 true JPH0155268B2 (ja) | 1989-11-22 |
Family
ID=12093552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2282883A Granted JPS59152373A (ja) | 1983-02-16 | 1983-02-16 | ïŒïŒïŒâãžãããããªãžã³èªå°äœ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59152373A (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1197012B (it) * | 1986-07-29 | 1988-11-25 | Boehringer Biochemia Srl | 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono |
JPH01216972A (ja) * | 1988-02-26 | 1989-08-30 | Banyu Pharmaceut Co Ltd | å åŠæŽ»æ§ãªïŒïŒïŒâãžãããããªãžã³èªå°äœããã®è£œé æ³åã³ãã®çšé |
EP0311053A3 (en) * | 1987-10-06 | 1991-05-08 | Banyu Pharmaceutical Co., Ltd. | Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use |
-
1983
- 1983-02-16 JP JP2282883A patent/JPS59152373A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS59152373A (ja) | 1984-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4705797A (en) | N-(3,3-diphenylpropyl) aminoethyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid, compositions and use | |
US4707486A (en) | Diaryl piperidine containing esters of 1,4-dihydropyridines and coronary therapeutic use | |
JPH02348B2 (ja) | ||
JPS6339588B2 (ja) | ||
JPS6360755B2 (ja) | ||
CA1175438A (en) | 1,4-dihydropyridine compounds having different substituents in the 2-position and 6-position, their production, and their medicinal use | |
US4937242A (en) | 1,4-dihydropyridine derivatives and pharmaceutical composition thereof | |
HU204786B (en) | Process for producing new dihydropyridine amide derivatives and pharmaceutical compositions comprising such compounds | |
JPH036151B2 (ja) | ||
JPH0155268B2 (ja) | ||
EP0257616A2 (en) | Dihydropyridine derivates and pharmaceutical composition thereof | |
JPH0515704B2 (ja) | ||
EP0106276B1 (en) | 1,4-dihydropyridine derivatives | |
US5064839A (en) | 1,4-dihydropyridines with a 2-amino group or with an ether group in a side chain | |
EP0220653A2 (en) | 3-Aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds, process for preparation and use thereof, and pharmaceutical composition containing the same | |
HUT52055A (en) | Process for producing basic 4-aryl-dihydropyridin-amides and pharmaceutical compositions containing them | |
Valenti et al. | Coumarin 1, 4-dihydropyridine derivatives | |
EP0220917B1 (en) | 1,4-dihydropyridine pharmaceutical derivatives and their salts, and the preparation thereof | |
JPH0714931B2 (ja) | æ°èŠãžãããããªãžã³èªå°äœããã®è£œæ³ããã³çšé | |
JPS6112663A (ja) | å åŠçã«æŽ»æ§ãªïŒïŒïŒâãžãããããªãžã³é¡ã®è£œé æ¹æ³ | |
EP0370821B1 (en) | 1,4-dihydropyridine derivatives | |
JPH0527624B2 (ja) | ||
SK47794A3 (en) | Chinolyl-dihydropyridinecarboxylic acid esters, method of their production, medicines containing these matters, method of their production and using of these compounds | |
EP0216542B1 (en) | Dihydropyridine derivatives | |
JPH0437834B2 (ja) |